Delivery Order SPE2DB24D1205-SPE2DB25FDAVW
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,785.38 to AmerisourceBergen Drug Corp for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28, with an ultimate completion date of September 10, 2025. This award represents a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a $2,816.89 delivery order to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on August 21, 2025, with completion scheduled for August 22, 2025. This contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.56 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count), a hormonal contraceptive medication. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a $1,404.76 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol-Norethindrone 0.5-0.1 mg tablets (28-count units), with an ultimate completion date of April 23, 2025. This is a firm fixed-price, non-set-aside contract executed on April 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norethindrone-Ethinyl Estradiol 0.5-2.5mg tablets (28-count package), with a contract ceiling value of $1,232.93. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for completion by September 17, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken,...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of drospirenone-ee 3-0.02 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $1,619.08 and a performance period through July 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $1,034.44 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DROSPIRENONE-EE 3-0.02 MG TAB 28S medication, with a performance period ending on May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC provides a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,217.22 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg in a 28-tablet package. This non-set-aside, firm fixed price delivery order was competitively awarded and is scheduled for completion by August 28, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,861.20 to AmerisourceBergen Drug Corp for Tri-Lo-Estarylla Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, issued on September 29, 2025, with a completion date of September 30, 2025, represents a non-competitive set-aside contract supporting the military's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...